These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 14702928)
21. A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial. Rosenoff SH; Gabrail NY; Conklin R; Hohneker JA; Berg WJ; Warsi G; Maloney J; Benedetto JJ; Miles EA; Zhu W; Anthony L J Support Oncol; 2006 Jun; 4(6):289-94. PubMed ID: 16805331 [TBL] [Abstract][Full Text] [Related]
22. Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315. Zachariah B; Gwede CK; James J; Ajani J; Chin LJ; Donath D; Rosenthal SA; Kane BL; Rotman M; Berk L; Kachnic LA J Natl Cancer Inst; 2010 Apr; 102(8):547-56. PubMed ID: 20339140 [TBL] [Abstract][Full Text] [Related]
23. Comprehensive Geriatric Assessment and Caring for the Older Person with Cancer. Overcash J; Momeyer MA Semin Oncol Nurs; 2017 Nov; 33(4):440-448. PubMed ID: 28927761 [TBL] [Abstract][Full Text] [Related]
24. Treatment-related diarrhea in patients with cancer. Shaw C; Taylor L Clin J Oncol Nurs; 2012 Aug; 16(4):413-7. PubMed ID: 22842693 [TBL] [Abstract][Full Text] [Related]
25. Octreotide in the treatment of severe chemotherapy-induced diarrhea. Zidan J; Haim N; Beny A; Stein M; Gez E; Kuten A Ann Oncol; 2001 Feb; 12(2):227-9. PubMed ID: 11300329 [TBL] [Abstract][Full Text] [Related]
26. Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial. Cascinu S; Fedeli A; Fedeli SL; Catalano G J Clin Oncol; 1993 Jan; 11(1):148-51. PubMed ID: 8418225 [TBL] [Abstract][Full Text] [Related]
27. Palliative radiotherapy and oncology nursing. McMenamin E; Ross N; Jones J Semin Oncol Nurs; 2014 Nov; 30(4):242-52. PubMed ID: 25361876 [TBL] [Abstract][Full Text] [Related]
28. A double blind crossover comparison of loperamide with diphenoxylate in the symptomatic treatment of chronic diarrhea. Pelemans W; Vantrappen F Gastroenterology; 1976 Jun; 70(6):1030-4. PubMed ID: 773736 [TBL] [Abstract][Full Text] [Related]
29. Managing complications in cancer: identifying and responding to the patient's perspective. Zabora JR; Loscalzo MJ; Weber J Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 2):1-9. PubMed ID: 14702915 [TBL] [Abstract][Full Text] [Related]
31. Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma. Petrelli NJ; Rodriguez-Bigas M; Rustum Y; Herrera L; Creaven P Cancer; 1993 Sep; 72(5):1543-6. PubMed ID: 8348489 [TBL] [Abstract][Full Text] [Related]
32. The role of loperamide in gastrointestinal disorders. Hanauer SB Rev Gastroenterol Disord; 2008; 8(1):15-20. PubMed ID: 18477966 [TBL] [Abstract][Full Text] [Related]
33. Prostaglandin-induced diarrhoea treated with loperamide or diphenoxylate. A double-blind study. Lange AP; Secher NJ; Amery W Acta Med Scand; 1977; 202(6):449-54. PubMed ID: 339672 [TBL] [Abstract][Full Text] [Related]
34. Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 8: Clinical investigation. Use of a flexible dosage schedule in a double-blind comparison of loperamide with diphenoxylate in 614 patients suffering from acute diarrhea. Dom J; Leyman R; Schuermans V; Brugmans J Arzneimittelforschung; 1974 Oct; 24(10):1660-5. PubMed ID: 4611434 [No Abstract] [Full Text] [Related]